A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan
A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan. // Obesity Research & Clinical Practice. – URL: https://www.sciencedirect.com/science/article/pii/S1871403X26000852?dgcid=rss_sd_all
A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan. Obesity Research & Clinical Practice. https://www.sciencedirect.com/science/article/pii/S1871403X26000852?dgcid=rss_sd_all
“A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan.” Obesity Research & Clinical Practice.
@article{article60599,
title = {A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan},
journal = {Obesity Research \& Clinical Practice},
url = {https://www.sciencedirect.com/science/article/pii/S1871403X26000852?dgcid=rss_sd_all}
}